Contact us Career

AI in Drug Discovery Market By Component (Software, Service), Technology (ML, DL), By Application (Immuno-oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, and Other Applications), By End User (Pharmaceutical & Biotechnology, CRO, and Research Centers and Academic & Government Institutes), By Geography (North America, Europe, APAC, and RoW) - Global Opportunity Analysis and Industry Forecast up to 2026

  • July, 2020
  • Domain: Healthcare - Pharmaceuticals
Pages: 88
Tables: 109
Charts: 140
Regions/Countries: 4 / 9
Companies: 20
Enquiry Hours: 10
  • Get Free 10% Customization in this Report

Artificial intelligence is the simulation of human intelligence in machines that are designed to think like humans and copy their actions. This gives the potential to transform the pharmaceutical industry as well. Many pharma competitors are now investing in this technology at some level.

Research Methodology:

The AI in drug delivery market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology, along with an irreplaceable blend of primary insights. The real-time assessment of the market is an integral part of our market sizing and forecasting methodology. Our industry experts and panel of primary participants have helped in compiling relevant aspects with realistic parametric estimations for a comprehensive study. The participation share of different categories of primary participants is given below:

Global AI in Drug Discovery Market

There is a significant increase in the number of applications that focus on the target and drug discovery, preclinical and clinical development, and post-approval activities.  AI can help in improving the drug approval rates, reduce development costs, swift availability of medications, and help patients comply with their treatments. The global AI in the drug discovery market has a high demand due to its increasing need to shorten the drug discovery process in order to get drugs faster for treating various incurable and viral diseases. Moreover, AI plays an important role to understand the mechanism of disease by determining biomarkers and creating data or models for the drug discovery process which will ultimately drive the market over the next few years.

To use the opportunity of diversifying the drug pipelines, AI-enabled prediction tools can improve the speed, accuracy, and preclinical testing and also it can open new research leads by availing more competitive R&D strategies. Failure to demonstrate value compared to available therapies is a key factor undermining clinical trial progression. Finding new niches of competitive advantage could reduce withdrawals and improve asset sales.

AI in Drug Discovery Market

AI in drug discovery research report is segregated into the following segments:

By Component

  • Software
  • Services

By Technology

  • Machine Learning
  • Deep Learning

By Application

  • Immuno-oncology
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Metabolic Diseases
  • Other Applications        

By End User

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Research Centers and Academic & Government Institutes

The market value of AI in Drug Discovery recorded in 2020 is $343.78 million and predictions are made on its future growth at a CAGR of 43.24%. There are four major factors which are the result of its increasing growth:

  • Requisite control on Cost and Time of Drug Discovery & Development
  • Demanding requirement of precision medicine
  • Expanding Cross-Industry Collaborations and Partnerships
  • Growing number of troublemakers of AI drug discovery

AI in drug discovery has enlightened the productivity of medical facilities, and on the same page has helped in boosting care facilities. Extensive medical facilities always try to opt for better services and latest technologies with minimum space for mistakes. This technology has fastened the drug construction procedures for cases which need specialized medicinal attention, which subsequently decreases failure risks and also the cost of research & development procedures.

Some of the vital players within the space of AI in Drug Discovery are as follows;

  • IBM Corporation
  • Microsoft Corporation
  • Google Inc.
  • NVIDIA Corporation
  • Pfizer, Merck
  • GSK
  • Novartis
  • AstraZeneca
  • Abbvie
  • Elli Lilly
  • Atomwise, Inc
  • Deep Genomics
  • Cloud Pharmaceuticals
  • Exscientia
  • Cyclica
  • Numerate
  • Envisagenics
  • OWKIN, Inc.
  • Verge Genomics

Another important factor of reducing the drug price has pressured the drug manufacturers to boost the production of AI for the drug discovery market. Efficient working of AI reduced the failure rate of clinical trials and also eradicated the cost of length research and development in drug discovery. Another factor which can bolster the anticipated growth of the Global AI for the drug discovery market is the lack of skilled health care professionals.

Currently, only one out of ten drugs are approved after clinical trials. Mostly because of lack of effectiveness and safety issues. Considering the growing cost of bringing a drug into the market, a minimum of ten percent improvement in the prediction of accuracy can save billions of dollars invested on drug development for AI in Drug Discovery vendors which compensate for both the residential as well as commercial sectors. So, improving the accuracy of predictions on the efficacy and safety of drugs is highly required. With a predicted CAGR of 43.24%, we have a lot of opportunities at our disposal and this report will help in understanding the current market dynamics, changing needs, and innovations that might be needed to make the user experience enriching.

  • This report would be the foundation for any research on the AI in Drug Discovery, vendor capabilities, SWOT of the vendors and framework for data analysis for further advanced innovation
  • An insight to the major competitors in the market, their journey and the competitive edge which one should have to beat other players is given
  • The report contains an understanding of technological innovations and advanced solutions for the AI in Drug Discovery.
  1. Executive Summary
  2. Industry Outlook
    1. Industry Overview
    2. Industry Trends
  3. Market Snapshot
    1. Market Definition
    2. Market Outlook
    3. PEST Analysis
    4. Porter Five Forces
    5. Related Markets
  4. Market Characterisitics
    1. Market Evolution
    2. Market Trends and Impact
    3. Advantages/Disadvantages of Market
    4. Regulatory Impact
    5. Market Offerings
    6. Market Segmentation
    7. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
    8. DRO - Impact Analysis
  5. End User: Market Size & Analysis
    1. Overview
    2. Research Centers and Academic & Government Institutes
    3. Pharmaceutical & Biotechnology Companies
    4. Contract Research Organizations
  6. Application: Market Size & Analysis
    1. Overview
    2. Cardiovascular Diseases
    3. Metabolic Diseases
    4. Neurodegenerative Diseases
    5. Immuno-oncology
    6. Other Applications
  7. Technology: Market Size & Analysis
    1. Overview
    2. Machine Learning
      1. Deep Learning
      2. Supervised Learning
      3. Reinforcement Learning
      4. Unsupervised Learning
      5. Other Machine Learning Technlogies
    3. Others Technologies
  8. Offering: Market Size & Analysis
    1. Overview
    2. Services
    3. Software
  9. Geography: Market Size & Analysis
    1. Overview
    2. North America
    3. Europe
    4. Asia Pacific
    5. Rest of the World
  10. Competitive Landscape
    1. Competitor Comparison Analysis
    2. Market Developments
    3. Mergers and Acquisitions, Legal, Awards, Partnerships
    4. Product Launches and execution
  11. Vendor Profiles
    1. Microsoft Corporation
      1. Overview
      2. Product Offerings
      3. Geographic Revenue
      4. Business Units
      5. Developments
      6. SWOT Analysis
      7. Business Strategy
    2. NVIDIA Corporation
      1. Overview
      2. Product Offerings
      3. Geographic Revenue
      4. Business Units
      5. Developments
      6. SWOT Analysis
      7. Business Strategy
    3. IBM Corporation
      1. Overview
      2. Product Offerings
      3. Geographic Revenue
      4. Business Units
      5. Developments
      6. SWOT Analysis
      7. Business Strategy
    4. Google
      1. Overview
      2. Product Offerings
      3. Geographic Revenue
      4. Business Units
      5. Developments
      6. SWOT Analysis
      7. Business Strategy
    5. Atomwise, Inc
      1. Overview
      2. Product Offerings
      3. Geographic Revenue
      4. Business Units
      5. Developments
      6. SWOT Analysis
      7. Business Strategy
    6. Deep Genomics
      1. Overview
      2. Product Offerings
      3. Geographic Revenue
      4. Business Units
      5. Developments
      6. SWOT Analysis
      7. Business Strategy
    7. Cloud Pharmaceuticals, Inc
      1. Overview
      2. Product Offerings
      3. Geographic Revenue
      4. Business Units
      5. Developments
      6. SWOT Analysis
      7. Business Strategy
    8. Insilico Medicine
      1. Overview
      2. Product Offerings
      3. Geographic Revenue
      4. Business Units
      5. Developments
      6. SWOT Analysis
      7. Business Strategy
    9. Benevolentai
      1. Overview
      2. Product Offerings
      3. Geographic Revenue
      4. Business Units
      5. Developments
      6. SWOT Analysis
      7. Business Strategy
    10. Exscientia
      1. Overview
      2. Product Offerings
      3. Geographic Revenue
      4. Business Units
      5. Developments
      6. SWOT Analysis
      7. Business Strategy
  12. Companies to Watch
    1. Cyclica
      1. Overview
      2. Market
      3. Business Strategy
    2. Bioage
      1. Overview
      2. Market
      3. Business Strategy
    3. Numerate
      1. Overview
      2. Market
      3. Business Strategy
    4. Numedii, Inc.
      1. Overview
      2. Market
      3. Business Strategy
    5. Envisagenics
      1. Overview
      2. Market
      3. Business Strategy
    6. Twoxar, Incorporated
      1. Overview
      2. Market
      3. Business Strategy
    7. Owkin, Inc
      1. Overview
      2. Market
      3. Business Strategy
    8. Xtalpi, Inc
      1. Overview
      2. Market
      3. Business Strategy
    9. Verge Genomics
      1. Overview
      2. Market
      3. Business Strategy
    10. Berg LLC
      1. Overview
      2. Market
      3. Business Strategy
  13. Analyst Opinion
  14. Annexure
    1. Report Scope
    2. Market Definitions
    3. Research Methodology
      1. Data Collation and In-house Estimation
      2. Market Triangulation
      3. Forecasting
    4. Report Assumptions
    5. Declarations
    6. Stakeholders
    7. Abbreviations

Research Framework

Infoholic research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Primary & Secondary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting

Market related information is congregated from both primary and secondary sources.

Primary sources

involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

Secondary sources

include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.

Interested in this report?
Get your FREE sample now!

Select User License

$

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer 10% worth of FREE customization at the time of purchase